OncoVista Innovative Therapies, Inc. is a high-growth theragnostic (the fusion of therapeutic and diagnostic medicine for individual patients) company that identifies specific biomarkers in the bloodstream carried by CTC's to detect metastatic tumors. This technology allows an oncologist the unique ability to develop personalized, efficacious cancer treatments, thereby evaluating cancer therapeutic efficacy that can dramatically improve a patient's chance of survival. OncoVista also produces innovative drug discovery, registration strategies and emerging technologies allowing it to bring to market less toxic and highly effective anti-cancer drugs.